Physician profile

Scott M Labohn

Podiatrist · Zephyrhills, FL

NPI 1396722898

$1,724.25

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$408.31

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Wright Medical Technology, INC. $556.86 2019
Stryker Corporation $459.99 2019-2023 Augment Injectable, Allowrap
Organogenesis INC. $389.45 2019-2021
Paragon 28, INC. $109.38 2024 Jaws
Integra Lifesciences Corporation $91.63 2024 Integra, Integra Dermal Regeneration Template, Primatrix
Kci USA, INC. $74.03 2019
Smith+Nephew, INC. $28.31 2023 Panta 2, Integra Movement Great Toe System
Orthofix Medical, INC. $14.60 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Scott M Labohn

$1,724.25

in general payments reported 2019-2025

Years
2019-2024
Top company
Wright Medical Technology, INC.

https://glasscript.com/doctor/154265/scott-m-labohn

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.